Table 2A.

Effect of formononetin treatment on glycohaemoglobin and liver glycogen content.

Groups	HbA1c (%Hb)	Hepatic glycogen (mg/gm of tissue)
Normal control group	3.94 ± 0.39	281.8 ± 30.13
Diabetic control group	11.58 ± 1.54###	53.3 ± 8.27###
Diabetic + Formononetin (10 mg/kg, orally)	4.68 ± 0.21∗∗∗	181.7 ± 27.7∗∗
Diabetic + Formononetin (20 mg/kg, orally)	4.59 ± 0.46∗∗∗	173 ± 15.8∗∗
Diabetic + Formononetin (40 mg/kg, orally)	4.27 ± 0.25∗∗∗	271.1 ± 36.9∗∗∗
Diabetic + glipizide (5 mg/kg, orally)	4.56 ± 0.16∗∗∗	248.9 ± 30.3∗∗∗

Values are expressed as Mean ± SEM. ^∗∗p < 0.01, ^∗∗∗p < 0.001 when compared with diabetic control. ^###p < 0.001 when compared to normal control (n = 6).